Explore

Trendline Trendline
FaZe Vegas Achieves 3-0 Record in CDL Stage 3 Qualifying, Strengthening Position for Major Event

FaZe Vegas Achieves 3-0 Record in CDL Stage 3 Qualifying, Strengthening Position for Major Event

FaZe Vegas Achieves 3-0 Record in CDL Stage 3 Qualifying, Strengthening Position for Major Event
Trendline Trendline
FaZe Vegas Achieves 3-0 Record in CDL Stage 3 Qualifying

FaZe Vegas Achieves 3-0 Record in CDL Stage 3 Qualifying

FaZe Vegas Achieves 3-0 Record in CDL Stage 3 Qualifying
Trendline Trendline
FaZe Clan Secures Final Playoff Spot at BLAST Rivals Spring Event

FaZe Clan Secures Final Playoff Spot at BLAST Rivals Spring Event

FaZe Clan Secures Final Playoff Spot at BLAST Rivals Spring Event
Trendline Trendline
FaZe Clan Advances to BLAST Rivals Spring Playoffs After Defeating FURIA

FaZe Clan Advances to BLAST Rivals Spring Playoffs After Defeating FURIA

FaZe Clan Advances to BLAST Rivals Spring Playoffs After Defeating FURIA
Trendline Trendline
Epic Games Introduces Easy Anti-Cheat in Rocket League, Ending Popular Mod BakkesMod

Epic Games Introduces Easy Anti-Cheat in Rocket League, Ending Popular Mod BakkesMod

Epic Games Introduces Easy Anti-Cheat in Rocket League, Ending Popular Mod BakkesMod
Trendline Trendline
Bandai Namco Announces Remaster of Tales of Eternia for Nintendo Switch

Bandai Namco Announces Remaster of Tales of Eternia for Nintendo Switch

Bandai Namco Announces Remaster of Tales of Eternia for Nintendo Switch
Rapid Read Rapid Read
FDA Approves Brain-Zapping Device as Alternative to SSRIs for Depression Treatment

FDA Approves Brain-Zapping Device as Alternative to SSRIs for Depression Treatment

The FDA has approved a new device, the Flow FL-100, which uses transcranial direct-current stimulation (tDCS) to treat depression. Developed by Swedish company Flow Neuroscience, this device offers a non-pharmaceutical alternative to traditional antidepressants like SSRIs. The device, which has been used in Europe, delivers weak electrical currents to the brain and is designed for home use under remote supervision. While the US trial showed modest improvements in depression symptoms, the device was cleared as a first-line treatment option, potentially shifting the focus in psychiatry from medication to alternative therapies.
Rapid Read Rapid Read
Democratic Lawmakers Propose Bill to Raise Federal Minimum Wage to $25 by 2031

Democratic Lawmakers Propose Bill to Raise Federal Minimum Wage to $25 by 2031

Democratic representatives, including Delia Ramirez and Analilia Mejia, have introduced the Living Wage for All Act, aiming to increase the federal minimum wage to $25 per hour. This bill targets large employers to meet this wage by 2031, with smaller employers following by 2038. The current federal minimum wage of $7.25 has not changed since 2009, despite most states having higher local minimum wages. The proposal is backed by a coalition of advocacy groups, including One Fair Wage and the NAACP, who argue that the increase is necessary to meet the basic cost of living as calculated by MIT's living wage calculator.
Rapid Read Rapid Read
Pentagon Reports $25 Billion Spent in Two Months on Iran Conflict Amid Budget Scrutiny

Pentagon Reports $25 Billion Spent in Two Months on Iran Conflict Amid Budget Scrutiny

The Pentagon has reported an expenditure of $25 billion in the first 60 days of military operations against Iran. This information was disclosed during a congressional hearing where Jay Hurst, acting as the Pentagon's chief financial officer, testified about the Department of Defense's budget for 2027. The administration plans to request additional funds from Congress to cover munitions and operational costs. The hearing also marked the first public questioning of Defense Secretary Pete Hegseth and Gen. Dan Caine since the onset of Operation Epic Fury. Lawmakers expressed concerns about the Pentagon's budget increase and the strategic direction of the conflict with Iran, especially given the ongoing blockade of the Strait of Hormuz and Iran's continued nuclear ambitions.
Rapid Read Rapid Read
FDA Advisory Committee to Review AstraZeneca's Cancer Drug Applications Amid Concerns

FDA Advisory Committee to Review AstraZeneca's Cancer Drug Applications Amid Concerns

The FDA is set to hold its first drug-related advisory committee meeting in nine months to evaluate AstraZeneca's applications for two cancer drugs. The meeting will focus on the oral SERD drug camizestrant for HR-positive, HER2-negative breast cancer and the AKT inhibitor Truqap for metastatic hormone-sensitive prostate cancer. The FDA has raised questions about the clinical benefits and trial designs of these drugs, particularly regarding the validity of results and the timing of treatment interventions. The advisory panel will assess whether AstraZeneca has provided sufficient evidence to support the clinical benefits of these drugs.
Trendline Trendline
Amtrak Mimics Luxury Car Ads to Promote Train Travel

Amtrak Mimics Luxury Car Ads to Promote Train Travel

Amtrak Mimics Luxury Car Ads to Promote Train Travel
Rapid Read Rapid Read
China's Military Modernization and Leadership Purges Raise Concerns

China's Military Modernization and Leadership Purges Raise Concerns

China's military is undergoing significant changes with rapid modernization and leadership purges under President Xi Jinping. The People's Liberation Army (PLA) is expanding its capabilities in nuclear, maritime, cyber, and space domains, aiming to become world-class by 2027. However, the military has also been affected by purges, with a significant portion of senior officers being dismissed. These developments raise questions about China's military readiness and its implications for U.S.-China relations, particularly concerning the risk of conflict over Taiwan.